Toekn sale was postponed? I see that public sale mast had was in July-August, but now is end of August and still no ICO date?
No official dates for the token sale yet. The sale is managed by Bitcoin Suisse so just register and go through the KYC process for now  https://ico.bitcoinsuisse.ch/ |
|
|
|
The project in medical shpere. The idea is good. Soon it will be pre-sale and we will see the results.
ClinTex is aiming to transform the clinical trial process and experience to get the best results The Pre-Sale is planned to commence in Q4, 2018. Just follow the project on Telegram to get all the updates https://t.me/ClinTexCTi and https://t.me/ClinTexCTiNews |
|
|
|
|
There are 4 phases in the current clinical trials. In the first phase of a clinical trial, the proposed drug safety is tested 1/1 and those tests last for more than two months and usually involve a number of healthy volunteers who are paid to be
part of the trial. The aim of this study is to observe how would the human body react to the tested drug or device and different dosages and intensity are included. The statistics showed the 70% of drugs/devices pass this phase.
The second phase tests the efficiency of the drug/device and usually lasts from several months to about two years. The number of volunteers in this phase jumps to hundreds of people. Many of the studies conducted in this phase are random and they are usually applied on two groups of people. The first group takes a dosage of the experimental drug while the other group takes a standard medication while thinking that they're taking the actual experimental drug. The researchers are unaware of the actual experiment too. This is done to observe the psychological effects and human behavior. By gathering this information, the investigators deliver comparative information about the safety and efficiency of the drug or device to pharmaceutical companies and the FDA. About 33.3% of the tested drugs or devices go through phase I and II.
The third phase of clinical trials are randomized as well and they usually have several hundred to thousands of volunteers. In this phase the scale of the testing is way bigger and testing a drug or device would take a minimum of 2 years or even more. By having a large number of volunteers, the investigators get a better understanding and more details on the effectiveness, benefits, and the possible harmful or unwanted reactions. When a drug/device passes this phase, pharmaceutical companies are able to request approval from the FDA to start marketing the drug.
The fourth phase and the last phase is named Post Marketing Surveillance Trial which is a study that starts after the drug or the device is available for consumer use. There are three main objectives of this study, first pharmaceutical companies compare the new drug or device to other existing drugs. Secondly, they observe the long-term effectiveness of the drug on the patient's progress and life quality. Third, they determine the cost-effectiveness of the new drug compared to existing or popular drugs. The results of this phase can lead to having the new drug or device taken off the market, or some restrictions may apply when using the new medicine or tool.
The cost of running these clinical trials is now higher than ever, with expenses running at between $30 million and $70 million for a single Phase III trial.
Integrating Blockchain technology with Clinical trials will give the following benefits:
1: Security to the clinical data and protection from any alteration
2: An immutable record that will show data and all changes in a consistent matter
3: Past data that will show the complete history of clinical information
4: peer-2peer payments via smart contracts
5: Operation interoperability between several systems and data formats
6: Protection of privacy is possible. Blockchain technology allows adding and verifying records to an immutable ledger without compromising the content of each record.
7: Control of access to the content of each record by using encryption keys. The public key shows that the record exists while the private key gives access to the content of the record.
|
|
|
|
The amount of tokens to be distrubuted in the bounty program is 356,945 SMARC tokens!
this is about 150-160k$ in ICO prices, but now the prices of tokens are falling strongly when entering the exchange, so where it will be 15-80k$, very smal pool We'll just have to wait until it hits exchange, but no current news on listings has been released yet. We will inform everybody when we have some news. Seems the math doesn't add up. The bounty rewards say 400k in USD. I'm looking forward to see the ICO funding report because it will determine the depth of a possible dump or not. The amount of tokens allocated to the bounty program is 356,945 SMARC tokens. There's an official Medium post about that https://medium.com/smart-containers/bounty-program-update-c51cd1399bd4 |
|
|
|
Thank you for not forgetting to inform us about the various changes and movements in Your wonderful team.I hope these are the people who will help to realize Your difficult and very interesting idea.I Wish You Success. You're most welcome and thank you for the support and engagement Sir Join the discussion on the Telegram group https://t.me/orvium |
|
|
|
Hello there, there are no confirmed dates for the token sale yet. The Pre-Sale will take place in Q4, 2018. The exact dates are to be announced. Just join the announcements channel then you will get updated once everything is confirmed 😊 https://t.me/ClinTexCTiNews |
|
|
|
I work in clinical trials and I can tell you the actual tool looks amazing. In the industry people have been saying for a long time that the correct predictive analytics in clinical trials will allow us to calculate if the medicine is gonna be successful even before the trial is over!
From the whitepaper, what’s different about this tool is that all the data from all the different clinical trial sources will now all be in one place. We could do good things when all this data is together. No one else is doing prediction on clinical trial data as far as I know – the market for this tool is huge
So do I, and the FDA chief has come out to signal he is supporting this approach too - the pharmaceutical companies like the one I work for are going to look to software like this - see https://www.mobihealthnews.com/content/fda-chief-sees-big-things-ai-healthcareIt makes sense, there are tens of thousands of clinical trials and hundreds of thousands of patients every year who could benefit from something like this CTi platform Indeed, ClinTex will be collecting this data by using IoT too and then everything will be analyzed using data mining and artificial intelligence. This data will be recorded on the blockchain from the moment of capturing it all the way to analyzing it. Make sure that join ClinTex on Telegram and Reddit guys Telegram group: https://t.me/ClinTexCTiTelegram channel: https://t.me/ClinTexCTiNewsReddit: https://www.reddit.com/r/ClinTexCTi |
|
|
|
|
Integrating Blockchain technology with Clinical trials will give the following benefits:
1: Security to the clinical data and protection from any alteration
2: An immutable record that will show data and all changes in a consistent matter
3: Past data that will show the complete history of clinical information
4: peer-2peer payments via smart contracts
5: Operation interoperability between several systems and data formats
|
|
|
|
Codex Protocol is already LIVE on the main Ethereum network. These are the main repertories on GitHub https://github.com/codex-protocol web.codex-viewerThe Codex Viewer is a dApp designed to view and manage assets created with Codex contract.codex-registry ERC-721 smart contracts for Codex Protocol service.codex-registry-apiNode API for Codex Registry npm.ethereum-service Ethereum Service & Codex Protocol Smart Contracts service.eelA simple service that listens for events emitted by Codex Protocol smart contracts on the Ethereum blockchain. contract.codex-coinERC-20 smart contract for Codex Protocol |
|
|
|
BLOCKCHAIN NEWSBlockchain Tech Poised to Reshape Medicines Development; Clinical trials research likely first to see benefits say expertsThe ClinTex project is still at the early fundraising stage, but it has already attracted attention from industry insiders like Clinical Commissioning Group Medicines Optimisation Pharmacist Michael Kolovetsios who wrote, “Running clinical trials today requires more effective data insights and better resource utilisation as clinical trials are more complex and costlier than ever. ClinTex CTi will deliver both the operational and clinical efficiency to the testing of new medicines, leading to faster data extraction and analysis. This will ultimately benefit patients, the pharmaceutical company, and society.” https://www.coinannouncer.com/blockchain-tech-poised-to-reshape-medicines-development-clinical-trials-research-likely-first-to-see-benefits-say-experts/
|
|
|
|
|
Show Posts
